Showing 1 - 5 results of 5 for search 'Winnie Janssens', query time: 0.04s Refine Results
  1. 1
    Hexavalent vaccines: increasing options for policy-makers and providers. A review of the data supporting interchangeability (substitution with vaccines containing fewer antigens) and mixed schedules from the same manufacturer

    Hexavalent vaccines: increasing options for policy-makers and providers. A review of the data supporting interchangeability (substitution with vaccines containing fewer antigens) a... by Jan Dolhain, Winnie Janssens, Narcisa Mesaros, Linda Hanssens, Frederik Fierens

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States

    Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus... by Nicola P. Klein, Remon Abu-Elyazeed, Brigitte Cheuvart, Winnie Janssens, Narcisa Mesaros

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa

    Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent D... by Timo Vesikari, Luis Rivera, Tiina Korhonen, Anitta Ahonen, Brigitte Cheuvart, Marjan Hezareh, Winnie Janssens, Narcisa Mesaros

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Long-term antibody persistence against hepatitis B in adolescents 14-15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy

    Long-term antibody persistence against hepatitis B in adolescents 14-15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy by Tino F. Schwarz, Ulrich Behre, Thomas Adelt, Matthias Donner, Pemmaraju V. Suryakiran, Winnie Janssens, Narcisa Mesaros, Falko Panzer

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study

    Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III,... by Victor Romanenko, Irina Osipova, Anna Galustyan, Michael Scherbakov, Nathalie Baudson, Déborah Farhi, Luis Anaya, Sherine O. Kuriyakose, Nadia Meyer, Winnie Janssens

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: